Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Amneal Pharmaceuticals, Inc. (AMRX)
USD16.95
-0.23 (-1.35%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
400 Crossing Boulevard 8807
Bridgewater, NJ, US
Bridgewater, NJ, US
CEO
Chirag K. Patel
Website
amneal.com
IPO
2018-05-07
CIK 1723128 ISIN US03168L1052
Description
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals. Key therapeutic areas for this segment include neurological conditions, endocrine disorders, and parasitic ailments, among others. Notable offerings include Emverm, a chewable tablet prescribed for single or mixed parasitic infections such as pinworm and various hookworms; Rytary, designed for the management of Parkinson's disease; and Unithroid, used in treating hypothyroidism. The AvKARE segment primarily serves governmental entities, particularly the Department of Defense and the Department of Veterans Affairs, supplying them with pharmaceuticals, medical and surgical supplies, and related services. Additionally, this segment engages in the bulk distribution of bottled and unit-dose pharmaceuticals under its AvKARE and AvPAK brands, alongside medical and surgical items. It also manages the packaging and large-scale distribution of medications and nutritional supplements for its retail and institutional clientele. Products from Amneal reach consumers through a network comprising wholesale suppliers, third-party distributors, hospitals, large pharmacy chains, and independent drugstores. Its operational footprint extends across the United States, India, Ireland, and other international markets. Established in 2002, the company was initially incorporated as Atlas Holdings, Inc., before adopting the name Amneal Pharmaceuticals, Inc. in 2018. Its corporate headquarters are situated in Bridgewater, New Jersey.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Date | Filing |
|---|---|---|
| Impax | 2017-11-21 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD16.95
-0.23 (-1.35%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.32
Float Shares
154.37M
Free Float %
48.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.41% | -7.49% | -1.79% | -14.98% | +9.38% | +0.00% | +68.00% | +523.76% | +129.93% | -56.82% | +165.26% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Buy
Price Targets & DCF
Current price
16.95
Low
15.00
-11.5%
Consensus
17.00
+0.3%
Median
17.00
+0.3%
High
19.00
+12.1%
DCF (Unlevered)
16.87
-0.5%
DCF (Levered)
12.18
-28.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
19.00
+12.1%
|
| Last Quarter | 2 |
18.00
+6.2%
|
| Last Year | 4 |
16.50
-2.6%
|
| All Time | 11 |
11.91
-29.7%
|
Quality scores
Altman Z-Score
2.13
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+8.1% ★ Q1'26: +3.9% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+157.9% ★ Q1'26: +405.3% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+2.6% Q1'26: -5.9% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+12.6% Q1'26: +18.5% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+14.4% ★ Q1'26: +20.5% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+5.1% Q1'26: +1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×4.53× Q1'26: 3.80× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.02B
est: 845.23M (+20.5%)
|
1.03B
est: 791.27M (+30.6%)
|
1.66B
est: 1.84B (-9.7%)
|
1.63B
est: 1.61B (+1.0%)
|
1.99B
est: 1.99B (+0.1%)
|
2.09B
est: 2.09B (+0.1%)
|
2.21B
est: 2.18B (+1.4%)
|
2.39B
est: 2.60B (-7.9%)
|
2.79B
est: 2.77B (+0.9%)
|
3.02B
est: 3.01B (+0.2%)
|
3.09B
3.08B – 3.11B
+2.7% YoY
|
3.33B
3.31B – 3.37B
+7.8% YoY
|
3.54B
3.52B – 3.56B
+6.0% YoY
|
| EBITDA |
306.97M
est: 157.32M (+95.1%)
|
271.13M
est: 147.28M (+84.1%)
|
-19.67M
est: 120.77M (-116.3%)
|
155.20M
est: 511.56M (-69.7%)
|
345.61M
est: 291.89M (+18.4%)
|
401.10M
est: 389.46M (+3.0%)
|
440.21M
est: 279.95M (+57.2%)
|
500.78M
est: 497.37M (+0.7%)
|
439.77M
est: 530.30M (-17.1%)
|
603.87M
est: 576.61M (+4.7%)
|
592.30M
590.40M – 596.11M
+2.7% YoY
|
638.39M
634.49M – 644.23M
+7.8% YoY
|
676.99M
673.03M – 680.95M
+6.0% YoY
|
| EBIT |
270.10M
est: 69.66M (+287.8%)
|
242.38M
est: 65.21M (+271.7%)
|
-59.15M
est: 2.83M (-2,190.7%)
|
-52.04M
est: -324.40M (+84.0%)
|
110.22M
est: 74.86M (+47.2%)
|
167.69M
est: 172.45M (-2.8%)
|
200.03M
est: -119.96M (+266.8%)
|
271.38M
est: 250.83M (+8.2%)
|
203.58M
est: 267.43M (-23.9%)
|
380.30M
est: 290.79M (+30.8%)
|
298.71M
297.75M – 300.63M
+2.7% YoY
|
321.95M
319.98M – 324.89M
+7.8% YoY
|
341.41M
339.41M – 343.41M
+6.0% YoY
|
| Net Income |
207.38M
est: 358.58M (-42.2%)
|
167.65M
est: 196.08M (-14.5%)
|
-169.73M
est: -138.73M (-22.3%)
|
-361.92M
est: -504.46M (+28.3%)
|
91.06M
est: 73.24M (+24.3%)
|
10.62M
est: 270.58M (-96.1%)
|
-129.99M
est: -2.05M (-6,247.0%)
|
-83.99M
est: -223.38M (+62.4%)
|
-116.89M
est: 198.57M (-158.9%)
|
72.06M
est: 261.48M (-72.4%)
|
321.11M
316.27M – 325.95M
+22.8% YoY
|
387.67M
369.37M – 405.98M
+20.7% YoY
|
444.53M
438.69M – 450.36M
+14.7% YoY
|
| SGA |
118.76M
est: 146.94M (-19.2%)
|
109.05M
est: 137.56M (-20.7%)
|
230.44M
est: 213.55M (+7.9%)
|
289.60M
est: 325.54M (-11.0%)
|
326.73M
est: 258.20M (+26.5%)
|
365.50M
est: 363.77M (+0.5%)
|
399.70M
est: 398.75M (+0.2%)
|
429.68M
est: 457.14M (-6.0%)
|
476.44M
est: 487.41M (-2.3%)
|
526.83M
est: 529.98M (-0.6%)
|
544.40M
542.65M – 547.90M
+2.7% YoY
|
586.76M
583.18M – 592.12M
+7.8% YoY
|
622.23M
618.59M – 625.87M
+6.0% YoY
|
| EPS |
1.10
est: 1.16 (-5.2%)
|
1.46
est: 0.63 (+130.1%)
|
-1.33
est: 0.90 (-248.2%)
|
-4.57
est: 0.32 (-1,524.1%)
|
0.62
est: 0.62 (-0.4%)
|
0.07
est: 0.88 (-92.0%)
|
-0.86
est: 0.66 (-231.3%)
|
-0.48
est: -0.69 (+30.2%)
|
-0.38
est: 0.61 (-162.0%)
|
0.23
est: 0.80 (-71.2%)
|
0.99
0.97 – 1.00
+24.2% YoY
|
1.20
1.14 – 1.25
+20.6% YoY
|
1.37
1.35 – 1.39
+14.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
259.80M
OE per share TTM
0.80
Owner's Yield
5.98%
Maintenance CapEx ratio
11.22%
Maint CapEx / Avg PPE
25.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
108
Total invested
325.78M
Insider transactions (90d)
16
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tushar Patel | 53.58M | 29.50% | 53.58M | — | 53.58M | 10.00 | IN | United States | 2019-08-26 | ↗ |
| 2 | Akram Mahesh | 30.38M | 9.90% | 30.38M | — | 30.38M | — | IN | United States | 2024-01-05 | ↗ |
| 3 | Chintu Patel | 24.78M | 8.30% | 24.78M | — | 24.78M | 10.00 | IN | United States | 2019-08-07 | ↗ |
| 4 | Chirag Patel | 21.30M | 7.10% | 21.30M | — | 21.30M | 10.00 | IN | United States | 2019-08-07 | ↗ |
| 5 | Fosun International Limited | 18.41M | 13.70% | — | 18.41M | — | 18.41M | CO | Citizenship or Place of Organization | 2020-02-14 | ↗ |
| 6 | Ambient Impact (HK) Limited | 16.44M | 12.30% | — | 16.44M | — | 16.44M | CO | Citizenship or Place of Organization | 2020-02-14 | ↗ |
| 7 | David Bonderman | 16.21M | 12.70% | — | 16.21M | — | — | IN | United States of America | 2019-07-19 | ↗ |
| 8 | TPG Group Holdings (SBS) Advisors, Inc. | 16.21M | 12.70% | — | — | — | — | CO | Delaware | 2019-07-19 | ↗ |
| 9 | Bonderman | 16.21M | 10.90% | — | 16.21M | — | — | IN | States of America | 2022-01-19 | ↗ |
| 10 | GP A, LLC | 16.21M | 10.90% | — | 16.21M | — | — | OO | Delaware | 2022-01-19 | ↗ |
| 11 | James G. Coulter | 16.21M | 10.90% | — | 16.21M | — | — | IN | States of America | 2022-01-19 | ↗ |
| 12 | Jon Winkelried | 16.21M | 10.90% | — | 16.21M | — | — | IN | States of America | 2022-01-19 | ↗ |
| 13 | Wellington Management Company LLP | 12.63M | 8.56% | — | 12.62M | — | — | IA | Massachusetts | 2021-02-03 | ↗ |
| 14 | The Vanguard Group - 23-1945930 | 11.57M | 7.75% | — | 206.7K | 11.29M | 283.6K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 15 | (1) BlackRock, Inc. | 7.34M | 4.97% | 7.24M | — | 7.34M | — | HC | Delaware | 2021-02-10 | ↗ |
| 16 | Abigail P. Johnson | 7.31M | 6.36% | — | — | 7.31M | — | IN | United States of America | 2019-02-13 | ↗ |
| 17 | FMR LLC | 7.31M | 6.36% | 446.4K | — | 7.31M | — | HC | Delaware | 2019-02-13 | ↗ |
| 18 | 52-0556948 | 4.43M | 3.30% | 1.59M | — | 4.43M | — | IA | Maryland | 2019-12-10 | ↗ |
| 19 | Fosun Industrial Co., Limited | 3.85M | 1.29% | — | 3.85M | — | 3.85M | CO | Citizenship or Place of Organization | 2018-05-14 | ↗ |
| 20 | Wellington Group Holdings LLP | 54.7K | 0.04% | — | 54.7K | — | — | HC | Massachusetts | 2021-04-12 | ↗ |
| 21 | Wellington Investment Advisors Holdings LLP | 54.7K | 0.04% | — | 54.7K | — | — | HC | Massachusetts | 2021-04-12 | ↗ |
| 22 | Wellington Management Group LLP | 54.7K | 0.04% | — | 54.7K | — | — | HC | Massachusetts | 2021-04-12 | ↗ |
| 23 | VANGUARD SPECIALIZED FUNDS - VANGUARD HEALTH CARE FUND - 23-2439149 | — | 0.00% | — | — | — | — | IV | Delaware | 2020-02-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
108
-172 vs prev Q
New positions
26
Closed positions
195
Increased
66
Reduced
24
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 17.91M -47.2K (-0.3%) | 225.64M +45.9M (+25.5%) | 5.70% -0.023 pp | 0.00% +0.001 pp | USD11.02 +14.3% | 31 qtrs — |
| 2 | BLACKROCK, INC. | 14.30M +224.9K (+1.6%) | 180.16M +39.3M (+27.9%) | 4.55% +0.066 pp | 0.00% +0.001 pp | USD8.61 +46.3% | 6 qtrs — |
| 3 | RUBRIC CAPITAL MANAGEMENT LP | 12.33M +— (+0.0%) | 155.42M +31.9M (+25.9%) | 3.93% -0.005 pp | 1.86% +0.466 pp | USD5.62 +124.2% | 11 qtrs — |
| 4 | TPG GP A, LLC | 12.33M +— (+0.0%) | 155.34M +31.9M (+25.9%) | 3.92% -0.005 pp | 5.78% -0.939 pp | USD4.79 +163.0% | 17 qtrs — |
| 5 | CITADEL ADVISORS LLC | 6.18M +446.4K (+7.8%) | 77.81M +20.5M (+35.7%) | 1.97% +0.140 pp | 0.01% +0.003 pp | USD6.37 +97.8% | 27 qtrs — |
| 6 | DIMENSIONAL FUND ADVISORS LP | 5.61M +177.9K (+3.3%) | 70.68M +16.3M (+30.0%) | 1.79% +0.054 pp | 0.01% +0.003 pp | USD6.26 +101.3% | 24 qtrs — |
| 7 | MORGAN STANLEY | 4.82M +1.3M (+37.5%) | 60.71M +25.6M (+73.1%) | 1.53% +0.417 pp | 0.00% +0.002 pp | USD9.01 +39.8% | 31 qtrs — |
| 8 | STATE STREET CORP | 4.11M +136.7K (+3.4%) | 51.79M +12.0M (+30.2%) | 1.31% +0.042 pp | 0.00% +0.000 pp | USD8.76 +43.8% | 31 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 3.99M -48.1K (-1.2%) | 50.24M +9.8M (+24.4%) | 1.27% -0.017 pp | 0.00% +0.001 pp | USD7.71 +63.4% | 31 qtrs — |
| 10 | ASSENAGON ASSET MANAGEMENT S.A. | 3.76M +1.6M (+75.0%) | 47.40M +25.9M (+120.2%) | 1.20% +0.512 pp | 0.07% +0.036 pp | USD10.52 +19.8% | 13 qtrs — |
| 11 | NEUBERGER BERMAN GROUP LLC | 3.66M -60.7K (-1.6%) | 46.10M +8.9M (+24.0%) | 1.16% -0.021 pp | 0.03% +0.007 pp | USD8.46 +48.9% | 31 qtrs — |
| 12 | MILLENNIUM MANAGEMENT LLC | 3.36M +27.4K (+0.8%) | 42.34M +9.0M (+26.9%) | 1.07% +0.007 pp | 0.02% +0.004 pp | USD7.85 +60.5% | 31 qtrs — |
| 13 | NUVEEN, LLC | 3.22M -3.5K (-0.1%) | 40.59M +8.3M (+25.7%) | 1.03% -0.003 pp | 0.01% +0.002 pp | USD8.64 +45.8% | 4 qtrs — |
| 14 | D. E. SHAW & CO., INC. | 2.66M +1.1M (+70.1%) | 33.54M +17.9M (+114.1%) | 0.85% +0.348 pp | 0.02% +0.010 pp | USD10.41 +21.0% | 4 qtrs — |
| 15 | GOLDMAN SACHS GROUP INC | 2.58M +120.9K (+4.9%) | 32.52M +7.9M (+32.1%) | 0.82% +0.037 pp | 0.00% +0.001 pp | USD7.76 +62.4% | 31 qtrs — |
| 16 | NANTAHALA CAPITAL MANAGEMENT, LLC | 2.45M -1.8M (-42.1%) | 30.84M -11.4M (-27.1%) | 0.78% -0.568 pp | 1.02% -0.449 pp | USD5.14 +145.1% | 12 qtrs — |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.14M +61.7K (+3.0%) | 27.02M +6.2M (+29.6%) | 0.68% +0.019 pp | 0.00% +0.001 pp | USD9.28 +35.8% | 31 qtrs — |
| 18 | ACADIAN ASSET MANAGEMENT LLC | 2.02M -569.4K (-22.0%) | 25.46M -458.0K (-1.8%) | 0.64% -0.182 pp | 0.04% -0.003 pp | USD7.66 +64.5% | 9 qtrs — |
| 19 | INVESCO LTD. | 1.75M +65.3K (+3.9%) | 22.06M +5.2M (+30.8%) | 0.56% +0.020 pp | 0.00% +0.001 pp | USD8.12 +55.2% | 31 qtrs — |
| 20 | BLACKBARN CAPITAL PARTNERS LP | 1.57M -619.5K (-28.3%) | 19.78M -2.1M (-9.7%) | 0.50% -0.198 pp | 1.30% -0.268 pp | USD6.98 +80.5% | 8 qtrs — |
| 21 | NORTHERN TRUST CORP | 1.55M -81.9K (-5.0%) | 19.48M +3.2M (+19.5%) | 0.49% -0.027 pp | 0.00% +0.000 pp | USD10.42 +20.9% | 31 qtrs — |
| 22 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 1.48M +344.4K (+30.3%) | 18.74M +6.9M (+58.9%) | 0.47% +0.109 pp | 0.03% +0.011 pp | USD10.37 +21.5% | 17 qtrs — |
| 23 | PFM HEALTH SCIENCES, LP | 1.47M +1.1M (+311.9%) | 18.47M +14.9M (+418.4%) | 0.47% +0.353 pp | 1.84% +1.567 pp | USD11.97 +5.3% | 2 qtrs — |
| 24 | WESTSHORE WEALTH, LLC | 1.38M +— (+0.0%) | 17.41M +3.6M (+25.9%) | 0.44% -0.001 pp | 5.76% +1.035 pp | USD10.01 +25.9% | 2 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.33M +47.9K (+3.7%) | 16.71M +3.9M (+30.6%) | 0.42% +0.015 pp | 0.00% +0.001 pp | USD8.53 +47.7% | 31 qtrs — |
| 26 | AMERIPRISE FINANCIAL INC | 1.28M -188.4K (-12.8%) | 16.17M +1.4M (+9.8%) | 0.41% -0.061 pp | 0.00% +0.000 pp | USD8.29 +52.0% | 19 qtrs — |
| 27 | PHOCAS FINANCIAL CORP. | 1.28M -2.8K (-0.2%) | 16.17M +3.3M (+25.6%) | 0.41% -0.002 pp | 2.10% +0.434 pp | USD6.67 +88.9% | 9 qtrs — |
| 28 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.21M -546.9K (-31.1%) | 15.26M -2.3M (-13.3%) | 0.39% -0.175 pp | 0.02% -0.003 pp | USD7.58 +66.2% | 9 qtrs — |
| 29 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.09M -207.3K (-16.0%) | 13.74M +748.7K (+5.8%) | 0.35% -0.067 pp | 0.01% 0.000 pp | USD7.26 +73.6% | 13 qtrs — |
| 30 | JAIN GLOBAL LLC | 1.06M +499.3K (+88.9%) | 13.37M +7.7M (+137.8%) | 0.34% +0.159 pp | 0.06% +0.038 pp | USD10.23 +23.2% | 4 qtrs — |
| 31 | AQR CAPITAL MANAGEMENT LLC | 1.05M +32.1K (+3.2%) | 13.18M +3.0M (+29.9%) | 0.33% +0.010 pp | 0.01% +0.000 pp | USD6.58 +91.5% | 16 qtrs — |
| 32 | TUCKER ASSET MANAGEMENT LLC | 1.01M -100.0K (-9.0%) | 12.74M +1.6M (+14.5%) | 0.32% -0.032 pp | 3.71% +0.358 pp | USD6.42 +96.3% | 7 qtrs — |
| 33 | PENN CAPITAL MANAGEMENT COMPANY, LLC | 1.00M +1.0M (+100.0%) | 12.66M +12.7M (+100.0%) | 0.32% +0.319 pp | 1.01% +1.009 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 34 | JANE STREET GROUP, LLC | 975.5K +203.1K (+26.3%) | 12.29M +4.6M (+59.0%) | 0.31% +0.064 pp | 0.00% +0.001 pp | USD9.88 +27.5% | 10 qtrs — |
| 35 | UBS GROUP AG | 935.5K -510.3K (-35.3%) | 11.79M -2.7M (-18.6%) | 0.30% -0.163 pp | 0.00% 0.000 pp | USD6.57 +91.8% | 31 qtrs — |
| 36 | NORGES BANK | 889.5K +889.5K (+100.0%) | 11.21M +11.2M (+100.0%) | 0.28% +0.283 pp | 0.00% +0.001 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 37 | VOLEON CAPITAL MANAGEMENT LP | 860.7K +448.5K (+108.8%) | 10.84M +6.7M (+162.8%) | 0.27% +0.143 pp | 0.23% +0.133 pp | USD11.21 +12.4% | 5 qtrs — |
| 38 | NEW YORK STATE COMMON RETIREMENT FUND | 841.2K +620.6K (+281.3%) | 10.60M +8.4M (+379.9%) | 0.27% +0.197 pp | 0.01% +0.011 pp | USD11.21 +12.4% | 31 qtrs — |
| 39 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 826.0K +83.2K (+11.2%) | 10.41M +3.0M (+40.0%) | 0.26% +0.026 pp | 0.08% +0.006 pp | USD9.03 +39.5% | 7 qtrs — |
| 40 | SG AMERICAS SECURITIES, LLC | 784.8K +758.3K (+2,866.0%) | 9.89M +9.6M (+3,631.7%) | 0.25% +0.241 pp | 0.01% +0.012 pp | USD12.45 +1.2% | 14 qtrs — |
| 41 | HILLSDALE INVESTMENT MANAGEMENT INC. | 714.5K -1.5K (-0.2%) | 9.00M +1.8M (+25.6%) | 0.23% -0.001 pp | 0.25% +0.032 pp | USD10.01 +25.9% | 4 qtrs — |
| 42 | BNP PARIBAS ARBITRAGE, SNC | 703.7K +364.8K (+107.7%) | 8.87M +5.5M (+161.4%) | 0.22% +0.116 pp | 0.00% +0.002 pp | USD10.68 +18.0% | 31 qtrs — |
| 43 | RAYMOND JAMES FINANCIAL INC | 698.1K -44.4K (-6.0%) | 8.80M +1.4M (+18.4%) | 0.22% -0.014 pp | 0.00% +0.000 pp | USD8.17 +54.2% | 5 qtrs — |
| 44 | BALYASNY ASSET MANAGEMENT L.P. | 689.9K +43.7K (+6.8%) | 8.69M +2.2M (+34.4%) | 0.22% +0.014 pp | 0.01% +0.003 pp | USD9.67 +30.3% | 5 qtrs — |
| 45 | JPMORGAN CHASE & CO | 662.6K -108.6K (-14.1%) | 8.35M +629.6K (+8.2%) | 0.21% -0.035 pp | 0.00% +0.000 pp | USD7.31 +72.4% | 31 qtrs — |
| 46 | FIRST TRUST ADVISORS LP | 640.3K +20.3K (+3.3%) | 8.07M +1.9M (+30.0%) | 0.20% +0.006 pp | 0.01% +0.001 pp | USD7.32 +72.1% | 7 qtrs — |
| 47 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 563.7K +328.3K (+139.4%) | 7.10M +4.7M (+201.4%) | 0.18% +0.104 pp | 0.03% +0.017 pp | USD11.52 +9.4% | 4 qtrs — |
| 48 | SEI INVESTMENTS CO | 559.4K +88.3K (+18.7%) | 7.05M +2.3M (+49.5%) | 0.18% +0.028 pp | 0.01% +0.002 pp | USD8.45 +49.1% | 31 qtrs — |
| 49 | ALLIANCEBERNSTEIN L.P. | 529.8K +217.3K (+69.5%) | 6.68M +3.5M (+113.4%) | 0.17% +0.069 pp | 0.00% +0.001 pp | USD10.01 +25.9% | 31 qtrs — |
| 50 | BANK OF NEW YORK MELLON CORP | 495.8K -104.4K (-17.4%) | 6.25M +239.7K (+4.0%) | 0.16% -0.034 pp | 0.00% 0.000 pp | USD6.67 +88.9% | 31 qtrs — |
| 51 | BANK OF AMERICA CORP /DE/ | 451.2K -211.7K (-31.9%) | 5.68M -951.0K (-14.3%) | 0.14% -0.068 pp | 0.00% +0.000 pp | USD7.64 +64.9% | 31 qtrs — |
| 52 | EAM INVESTORS, LLC | 425.7K +425.7K (+100.0%) | 5.36M +5.4M (+100.0%) | 0.14% +0.136 pp | 0.60% +0.597 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 53 | FRANKLIN RESOURCES INC | 414.5K +320.5K (+340.9%) | 5.22M +4.3M (+455.0%) | 0.13% +0.102 pp | 0.00% +0.001 pp | USD10.85 +16.1% | 10 qtrs — |
| 54 | PRUDENTIAL FINANCIAL INC | 406.1K -740.8K (-64.6%) | 5.12M -6.4M (-55.4%) | 0.13% -0.236 pp | 0.01% -0.008 pp | USD4.35 +189.7% | 31 qtrs — |
| 55 | SEGALL BRYANT & HAMILL, LLC | 391.8K -4.0K (-1.0%) | 4.94M +974.7K (+24.6%) | 0.12% -0.001 pp | 0.07% +0.014 pp | USD6.45 +95.3% | 7 qtrs — |
| 56 | RUSSELL INVESTMENTS GROUP, LTD. | 389.4K -156.7K (-28.7%) | 4.93M -512.7K (-9.4%) | 0.12% -0.050 pp | 0.01% -0.001 pp | USD7.05 +78.7% | 24 qtrs — |
| 57 | ALGERT GLOBAL LLC | 381.8K -568.3K (-59.8%) | 4.81M -4.7M (-49.4%) | 0.12% -0.181 pp | 0.08% -0.084 pp | USD6.76 +86.4% | 20 qtrs — |
| 58 | FMR LLC | 377.0K +83.5K (+28.4%) | 4.75M +1.8M (+61.7%) | 0.12% +0.026 pp | 0.00% +0.000 pp | USD7.86 +60.3% | 16 qtrs — |
| 59 | BARCLAYS PLC | 361.2K +64.9K (+21.9%) | 4.55M +2.1M (+84.6%) | 0.12% +0.021 pp | 0.00% +0.001 pp | USD8.39 +50.2% | 31 qtrs — |
| 60 | MARINER, LLC | 345.2K -49.9K (-12.6%) | 4.35M +395.0K (+10.0%) | 0.11% -0.016 pp | 0.01% +0.000 pp | USD7.88 +59.9% | 9 qtrs — |
| 61 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 328.0K +— (+0.0%) | 4.13M +849.5K (+25.9%) | 0.10% 0.000 pp | 0.06% +0.012 pp | USD8.61 +46.3% | 4 qtrs — |
| 62 | SWISS NATIONAL BANK | 309.6K +5.9K (+1.9%) | 3.90M +860.9K (+28.3%) | 0.10% +0.002 pp | 0.00% +0.001 pp | USD6.63 +90.0% | 9 qtrs — |
| 63 | TWO SIGMA INVESTMENTS, LP | 301.0K +231.5K (+332.9%) | 3.79M +3.1M (+444.9%) | 0.10% +0.074 pp | 0.01% +0.004 pp | USD11.91 +5.8% | 13 qtrs — |
| 64 | CITIGROUP INC | 280.5K -2.4K (-0.8%) | 3.53M +702.6K (+24.8%) | 0.09% -0.001 pp | 0.00% +0.000 pp | USD8.38 +50.4% | 31 qtrs — |
| 65 | UBS ASSET MANAGEMENT AMERICAS INC | 243.1K +9.2K (+3.9%) | 3.06M +722.2K (+30.8%) | 0.08% +0.003 pp | 0.00% +0.000 pp | USD7.47 +68.7% | 8 qtrs — |
| 66 | JUMP FINANCIAL, LLC | 236.4K -68.2K (-22.4%) | 2.98M -70.4K (-2.3%) | 0.08% -0.022 pp | 0.04% +0.000 pp | USD8.32 +51.4% | 5 qtrs — |
| 67 | ENVESTNET ASSET MANAGEMENT INC | 235.3K +74.7K (+46.5%) | 2.96M +1.4M (+84.4%) | 0.07% +0.024 pp | 0.00% +0.000 pp | USD10.83 +16.3% | 2 qtrs — |
| 68 | JACKSON CREEK INVESTMENT ADVISORS LLC | 222.1K -10.4K (-4.5%) | 2.80M +472.0K (+20.3%) | 0.07% -0.003 pp | 0.83% +0.154 pp | USD7.01 +79.7% | 7 qtrs — |
| 69 | CREDIT AGRICOLE S A | 214.3K +214.3K (+100.0%) | 2.70M +2.7M (+100.0%) | 0.07% +0.068 pp | 0.01% +0.006 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 70 | MARTINGALE ASSET MANAGEMENT L P | 209.8K +9.6K (+4.8%) | 2.64M +640.0K (+31.9%) | 0.07% +0.003 pp | 0.07% +0.017 pp | USD7.75 +62.6% | 8 qtrs — |
| 71 | RHUMBLINE ADVISERS | 200.8K -31.4K (-13.5%) | 2.53M +206.1K (+8.9%) | 0.06% -0.010 pp | 0.00% +0.000 pp | USD8.60 +46.5% | 31 qtrs — |
| 72 | LSV ASSET MANAGEMENT | 197.3K +— (+0.0%) | 2.49M +511.0K (+25.9%) | 0.06% 0.000 pp | 0.01% +0.001 pp | USD8.61 +46.3% | 4 qtrs — |
| 73 | STIFEL FINANCIAL CORP | 188.3K -1.9K (-1.0%) | 2.37M +469.3K (+24.7%) | 0.06% -0.001 pp | 0.00% +0.000 pp | USD4.39 +187.0% | 18 qtrs — |
| 74 | MACKENZIE FINANCIAL CORP | 181.8K -14.0K (-7.1%) | 2.34M +377.1K (+19.2%) | 0.06% -0.005 pp | 0.00% +0.000 pp | USD8.08 +55.9% | 13 qtrs — |
| 75 | PDT PARTNERS, LLC | 180.6K +— (+0.0%) | 2.28M +467.8K (+25.9%) | 0.06% 0.000 pp | 0.15% +0.034 pp | USD8.23 +53.1% | 5 qtrs — |
| 76 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 175.4K -5.8K (-3.2%) | 2.21M +396.2K (+21.8%) | 0.06% -0.002 pp | 0.00% +0.000 pp | USD6.33 +99.1% | 8 qtrs — |
| 77 | WELLS FARGO & COMPANY/MN | 172.7K +76.8K (+80.0%) | 2.18M +1.2M (+126.6%) | 0.06% +0.024 pp | 0.00% +0.000 pp | USD9.76 +29.1% | 31 qtrs — |
| 78 | SQUAREPOINT OPS LLC | 168.6K -371.6K (-68.8%) | 2.12M -3.3M (-60.7%) | 0.05% -0.119 pp | 0.00% -0.003 pp | USD8.02 +57.1% | 7 qtrs — |
| 79 | STATE OF WISCONSIN INVESTMENT BOARD | 168.5K +68.4K (+68.3%) | 2.12M +1.1M (+111.8%) | 0.05% +0.022 pp | 0.00% +0.002 pp | USD9.17 +37.4% | 31 qtrs — |
| 80 | DARK FOREST CAPITAL MANAGEMENT LP | 158.0K -1.1K (-0.7%) | 1.99M +703.6K (+54.7%) | 0.05% 0.000 pp | 0.09% +0.052 pp | USD8.38 +50.4% | 6 qtrs — |
| 81 | OLIVER LUXXE ASSETS LLC | 156.5K +156.5K (+100.0%) | 1.97M +2.0M (+100.0%) | 0.05% +0.050 pp | 0.30% +0.300 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 82 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 156.3K +7.9K (+5.3%) | 1.97M +484.3K (+32.6%) | 0.05% +0.003 pp | 0.01% +0.002 pp | USD5.56 +126.6% | 10 qtrs — |
| 83 | PRINCIPAL FINANCIAL GROUP INC | 154.9K +46.4K (+42.8%) | 1.95M +865.9K (+79.8%) | 0.05% +0.015 pp | 0.00% +0.000 pp | USD8.02 +57.1% | 30 qtrs — |
| 84 | LOS ANGELES CAPITAL MANAGEMENT LLC | 194.7K -35.7K (-15.5%) | 1.95M -359.6K (-15.6%) | 0.06% -0.012 pp | 0.01% -0.001 pp | USD8.43 +49.5% | 4 qtrs — |
| 85 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 150.7K -130.0 (-0.1%) | 1.90M +388.9K (+25.8%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD7.94 +58.7% | 31 qtrs — |
| 86 | LEGAL & GENERAL GROUP PLC | 149.3K -15.0K (-9.1%) | 1.88M +236.5K (+14.4%) | 0.05% -0.005 pp | 0.00% +0.000 pp | USD6.67 +88.9% | 31 qtrs — |
| 87 | CONVERGENCE INVESTMENT PARTNERS, LLC | 146.4K +49.5K (+51.1%) | 1.85M +874.9K (+90.2%) | 0.05% +0.016 pp | 0.37% +0.149 pp | USD8.87 +42.1% | 7 qtrs — |
| 88 | PRICE T ROWE ASSOCIATES INC /MD/ | 144.7K +7.0K (+5.1%) | 1.82M +445.0K (+32.3%) | 0.05% +0.002 pp | 0.00% +0.000 pp | USD5.60 +125.0% | 14 qtrs — |
| 89 | HRT FINANCIAL LP | 144.6K +144.6K (+100.0%) | 1.82M +1.8M (+100.0%) | 0.05% +0.046 pp | 0.01% +0.006 pp | USD12.60 +0.0% | 3 qtrs — |
| 90 | GLOBEFLEX CAPITAL L P | 136.5K +104.3K (+324.1%) | 1.72M +1.4M (+433.9%) | 0.04% +0.033 pp | 0.26% +0.214 pp | USD10.93 +15.3% | 24 qtrs — |
| 91 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 131.6K +— (+0.0%) | 1.66M +340.8K (+25.9%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD8.38 +50.4% | 4 qtrs — |
| 92 | NUMERAI GP LLC | 124.9K +9.0K (+7.8%) | 1.57M +414.0K (+35.7%) | 0.04% +0.003 pp | 0.19% +0.026 pp | USD8.69 +45.0% | 4 qtrs — |
| 93 | ARTEMIS INVESTMENT MANAGEMENT LLP | 124.9K +124.9K (+100.0%) | 1.57M +1.6M (+100.0%) | 0.04% +0.040 pp | 0.02% +0.019 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 94 | DEUTSCHE BANK AG\ | 118.3K -835.5K (-87.6%) | 1.49M -8.1M (-84.4%) | 0.04% -0.266 pp | 0.00% -0.003 pp | USD8.65 +45.7% | 31 qtrs — |
| 95 | TWO SIGMA ADVISERS, LP | 117.0K +84.8K (+263.0%) | 1.47M +1.2M (+356.9%) | 0.04% +0.027 pp | 0.00% +0.002 pp | USD11.08 +13.7% | 26 qtrs — |
| 96 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111.4K +111.4K (+100.0%) | 1.40M +1.4M (+100.0%) | 0.04% +0.036 pp | 0.03% +0.029 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 97 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 110.0K +110.0K (+100.0%) | 1.39M +1.4M (+100.0%) | 0.04% +0.035 pp | 0.00% +0.003 pp | USD12.60 +0.0% | 1 qtrs NEW |
| 98 | HSBC HOLDINGS PLC | 101.9K +1.6K (+1.6%) | 1.30M +286.8K (+28.4%) | 0.03% +0.001 pp | 0.00% +0.000 pp | USD8.16 +54.4% | 17 qtrs — |
| 99 | RITHOLTZ WEALTH MANAGEMENT | 102.7K -699.0 (-0.7%) | 1.29M +259.1K (+25.0%) | 0.03% 0.000 pp | 0.02% +0.004 pp | USD5.18 +143.2% | 10 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
1.58
Bullish
Buys
16
Sells
8
Shares acquired
462.1K
Shares disposed
292.5K
Cash buys
—
Cash sales
—
Net activity
+169,605
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Yanai Shlomo | Director | M-Exempt | D | Restricted Stock Units | 34,819 | 0.00 | — | 0 | D | ↗ |
| 2026-05-07 | Patel Gautam | Director | M-Exempt | A | Class A Common Stock | 34,819 | 0.00 | — | 1,643,963 | D | ↗ |
| 2026-05-07 | Nark Ted C | Director | M-Exempt | D | Restricted Stock Units | 34,819 | 0.00 | — | 0 | D | ↗ |
| 2026-05-07 | MEISTER PAUL M | Director | M-Exempt | D | Restricted Stock Units | 48,747 | 0.00 | — | 0 | D | ↗ |
| 2026-05-07 | Kiely John | Director | M-Exempt | D | Restricted Stock Units | 34,819 | 0.00 | — | 0 | D | ↗ |
| 2026-05-07 | George Jeffrey P. | Director | M-Exempt | D | Restricted Stock Units | 34,819 | 0.00 | — | 0 | D | ↗ |
| 2026-05-07 | BUCHI J KEVIN | Director | M-Exempt | A | Class A Common Stock | 34,819 | 0.00 | — | 75,077 | D | ↗ |
| 2026-05-07 | Autor Deborah M. | Director | M-Exempt | D | Restricted Stock Units | 34,819 | 0.00 | — | 0 | D | ↗ |
| 2026-05-06 | Yanai Shlomo | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | Patel Gautam | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | Nark Ted C | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | MEISTER PAUL M | Director | A-Award | A | Restricted Stock Units | 30,837 | 0.00 | — | 30,837 | D | ↗ |
| 2026-05-06 | Kiely John | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | George Jeffrey P. | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | BUCHI J KEVIN | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-05-06 | Autor Deborah M. | Director | A-Award | A | Restricted Stock Units | 19,824 | 0.00 | — | 19,824 | D | ↗ |
| 2026-03-04 | Shah Nikita | Officer | F-InKind | D | Class A Common Stock | 17,976 | 13.30 | 239.1K | 399,793 | D | ↗ |
| 2026-03-04 | Patel Chirag K. | Director / Officer | M-Exempt | A | Class A Common Stock | 92,593 | 0.00 | — | 1,431,295 | D | ↗ |
| 2026-03-04 | Patel Chintu | Director / Officer | M-Exempt | A | Class A Common Stock | 92,593 | 0.00 | — | 1,417,504 | D | ↗ |
| 2026-03-04 | Konidaris Tasos | Officer | F-InKind | D | Class A Common Stock | 22,035 | 13.30 | 293.1K | 449,434 | D | ↗ |
| 2026-03-04 | Daly Jason B. | Officer | F-InKind | D | Class A Common Stock | 15,580 | 13.30 | 207.2K | 251,784 | D | ↗ |
| 2026-03-04 | BOYER ANDREW S | Officer | F-InKind | D | Class A Common Stock | 19,136 | 13.30 | 254.5K | 426,072 | D | ↗ |
| 2026-03-03 | Shah Nikita | Officer | F-InKind | D | Class A Common Stock | 22,982 | 13.31 | 305.9K | 187,022 | D | ↗ |
| 2026-03-03 | Patel Chirag K. | Director / Officer | M-Exempt | A | Class A Common Stock | 733,944 | 0.00 | — | 1,636,239 | D | ↗ |
| 2026-03-03 | Patel Chintu | Director / Officer | M-Exempt | A | Class A Common Stock | 733,944 | 0.00 | — | 1,640,796 | D | ↗ |
| 2026-03-03 | Konidaris Tasos | Officer | M-Exempt | D | Restricted Stock Units | 45,290 | 0.00 | — | 0 | D | ↗ |
| 2026-03-03 | Daly Jason B. | Officer | F-InKind | D | Class A Common Stock | 16,598 | 13.31 | 220.9K | 44,732 | D | ↗ |
| 2026-03-03 | BOYER ANDREW S | Officer | F-InKind | D | Class A Common Stock | 24,897 | 13.31 | 331.4K | 196,530 | D | ↗ |
| 2026-03-02 | Shah Nikita | Officer | A-Award | A | Performance-Based Restricted Stock Units | 65,359 | 0.00 | — | 65,359 | D | ↗ |
| 2026-03-02 | Patel Chirag K. | Director / Officer | A-Award | A | Restricted Stock Units | 190,632 | 0.00 | — | 190,632 | D | ↗ |
| 2026-03-02 | Patel Chintu | Director / Officer | A-Award | A | Restricted Stock Units | 190,632 | 0.00 | — | 190,632 | D | ↗ |
| 2026-03-02 | Konidaris Tasos | Officer | A-Award | A | Restricted Stock Units | 72,622 | 0.00 | — | 72,622 | D | ↗ |
| 2026-03-02 | Daly Jason B. | Officer | A-Award | A | Performance-Based Restricted Stock Units | 65,359 | 0.00 | — | 65,359 | D | ↗ |
| 2026-03-02 | BOYER ANDREW S | Officer | A-Award | A | Restricted Stock Units | 65,359 | 0.00 | — | 65,359 | D | ↗ |
| 2025-11-17 | Nark Ted C | Director | S-Sale | D | Class A Common Stock | 50,000 | 11.72 | 586.0K | 291,029 | D | ↗ |
| 2025-11-12 | Shah Nikita | Officer | M-Exempt | A | Class A Common Stock | 36,331 | 2.75 | 99.9K | 182,734 | D | ↗ |
| 2025-08-27 | Kiely John | Director | S-Sale | D | Class A Common Stock | 32,000 | 9.23 | 295.4K | 225,433 | D | ↗ |
| 2025-08-25 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 6,340 | 9.50 | 60.2K | 146,403 | D | ↗ |
| 2025-08-22 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 114,492 | 9.66 | 1.11M | 152,743 | D | ↗ |
| 2025-08-20 | BOYER ANDREW S | Officer | M-Exempt | A | Class A Common Stock | 175,000 | 2.75 | 481.3K | 431,670 | D | ↗ |
| 2025-08-15 | Konidaris Tasos | Officer | S-Sale | D | Class A Common Stock | 219,159 | 9.43 | 2.07M | 122,152 | D | ↗ |
| 2025-08-14 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 71,694 | 9.29 | 666.0K | 267,235 | D | ↗ |
| 2025-08-14 | Konidaris Tasos | Officer | S-Sale | D | Class A Common Stock | 119,206 | 9.30 | 1.11M | 341,311 | D | ↗ |
| 2025-08-13 | Konidaris Tasos | Officer | S-Sale | D | Class A Common Stock | 161,365 | 9.22 | 1.49M | 460,517 | D | ↗ |
| 2025-08-12 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 50,000 | 9.04 | 452.0K | 338,929 | D | ↗ |
| 2025-08-12 | Daly Jason B. | Officer | S-Sale | D | Class A Common Stock | 22,000 | 9.05 | 199.1K | 10,606 | D | ↗ |
| 2025-08-12 | BOYER ANDREW S | Officer | S-Sale | D | Class A Common Stock | 33,436 | 9.05 | 302.6K | 256,670 | D | ↗ |
| 2025-06-16 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 94,906 | 8.02 | 761.1K | 1,609,144 | D | ↗ |
| 2025-06-10 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 56,426 | 8.02 | 452.5K | 1,704,050 | D | ↗ |
| 2025-05-16 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 49,140 | 7.58 | 372.5K | 388,929 | D | ↗ |
| 2025-05-12 | Kiely John | Director | S-Sale | D | Class A Common Stock | 50,000 | 7.59 | 379.5K | 257,433 | D | ↗ |
| 2025-05-06 | Yanai Shlomo | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | Patel Gautam | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | Nark Ted C | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | MEISTER PAUL M | Director | A-Award | A | Restricted Stock Units | 48,747 | 0.00 | — | 48,747 | D | ↗ |
| 2025-05-06 | Kiely John | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | George Jeffrey P. | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | BUCHI J KEVIN | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | Autor Deborah M. | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-06 | Alva Emily Peterson | Director | A-Award | A | Restricted Stock Units | 34,819 | 0.00 | — | 34,819 | D | ↗ |
| 2025-05-05 | Yanai Shlomo | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Patel Gautam | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Nark Ted C | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | MEISTER PAUL M | Director | M-Exempt | D | Restricted Stock Units | 56,361 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Kiely John | Director | M-Exempt | A | Class A Common Stock | 40,258 | 0.00 | — | 307,433 | D | ↗ |
| 2025-05-05 | George Jeffrey P. | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | BUCHI J KEVIN | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Autor Deborah M. | Director | M-Exempt | D | Restricted Stock Units | 40,258 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Alva Emily Peterson | Director | M-Exempt | A | Class A Common Stock | 40,258 | 0.00 | — | 211,029 | D | ↗ |
| 2025-05-02 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 3,768 | 8.00 | 30.1K | 1,725,118 | D | ↗ |
| 2025-04-01 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 80,000 | 8.30 | 664.0K | 1,728,886 | D | ↗ |
| 2025-03-14 | Patel Tushar Bhikhubhai | 10% Owner | S-Sale | D | Class A Common Stock | 5,000,000 | 8.35 | 41.75M | 48,578,209 | I | ↗ |
| 2025-03-10 | BUCHI J KEVIN | Director | G-Gift | D | Class A Common Stock | 262,072 | 0.00 | — | 0 | D | ↗ |
| 2025-03-06 | Daly Jason B. | Officer | S-Sale | D | Class A Common Stock | 46,936 | 8.73 | 409.8K | 32,606 | D | ↗ |
| 2025-03-05 | Konidaris Tasos | Officer | S-Sale | D | Class A Common Stock | 100,000 | 8.91 | 891.0K | 621,882 | D | ↗ |
| 2025-03-05 | Daly Jason B. | Officer | S-Sale | D | Class A Common Stock | 43,064 | 8.88 | 382.4K | 79,542 | D | ↗ |
| 2025-03-05 | BOYER ANDREW S | Officer | S-Sale | D | Class A Common Stock | 125,000 | 8.89 | 1.11M | 290,106 | D | ↗ |
| 2025-03-05 | Alva Emily Peterson | Director | S-Sale | D | Class A Common Stock | 80,000 | 8.90 | 712.0K | 170,771 | D | ↗ |
| 2025-03-04 | Shah Nikita | Officer | M-Exempt | A | Class A Common Stock | 35,879 | 0.00 | — | 456,422 | D | ↗ |
| 2025-03-04 | Patel Chirag K. | Director / Officer | M-Exempt | D | Restricted Stock Units | 92,592 | 0.00 | — | 277,778 | D | ↗ |
| 2025-03-04 | Patel Chintu | Director / Officer | M-Exempt | D | Restricted Stock Units | 92,592 | 0.00 | — | 277,778 | D | ↗ |
| 2025-03-04 | Konidaris Tasos | Officer | M-Exempt | A | Class A Common Stock | 43,981 | 0.00 | — | 744,379 | D | ↗ |
| 2025-03-04 | Daly Jason B. | Officer | M-Exempt | A | Class A Common Stock | 35,879 | 0.00 | — | 138,185 | D | ↗ |
| 2025-03-04 | BOYER ANDREW S | Officer | F-InKind | D | Class A Common Stock | 19,537 | 8.84 | 172.7K | 415,106 | D | ↗ |
| 2025-03-03 | Shah Nikita | Officer | F-InKind | D | Class A Common Stock | 18,533 | 8.76 | 162.3K | 327,338 | D | ↗ |
| 2025-03-03 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 80,000 | 8.90 | 712.0K | 1,808,886 | D | ↗ |
| 2025-03-03 | Patel Chirag K. | Director / Officer | A-Award | A | Restricted Stock Units | 239,726 | 0.00 | — | 239,726 | D | ↗ |
| 2025-03-03 | Patel Chintu | Director / Officer | M-Exempt | A | Class A Common Stock | 579,710 | 0.00 | — | 1,092,276 | D | ↗ |
| 2025-03-03 | Konidaris Tasos | Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 181,159 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | Daly Jason B. | Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 90,580 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | BOYER ANDREW S | Officer | M-Exempt | A | Class A Common Stock | 39,251 | 0.00 | — | 315,555 | D | ↗ |
| 2025-03-01 | Shah Nikita | Officer | F-InKind | D | Class A Common Stock | 10,985 | 8.67 | 95.2K | 309,639 | D | ↗ |
| 2025-03-01 | Konidaris Tasos | Officer | F-InKind | D | Class A Common Stock | 13,494 | 8.67 | 117.0K | 550,019 | D | ↗ |
| 2025-03-01 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 31,371 | 0.00 | — | 0 | D | ↗ |
| 2025-02-03 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 80,000 | 8.14 | 651.2K | 1,888,886 | D | ↗ |
| 2025-01-08 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 62,590 | 8.01 | 501.3K | 1,968,886 | D | ↗ |
| 2025-01-02 | Patel Gautam | Director | S-Sale | D | Class A Common Stock | 17,410 | 8.01 | 139.5K | 2,031,476 | D | ↗ |
| 2024-11-22 | Kiely John | Director | M-Exempt | A | Class A Common Stock | 28,506 | 4.76 | 135.7K | 284,233 | D | ↗ |
| 2024-11-22 | Autor Deborah M. | Director | S-Sale | D | Class A Common Stock | 33,229 | 8.34 | 277.1K | 53,402 | D | ↗ |
| 2024-11-21 | Daly Jason B. | Officer | S-Sale | D | Class A Common Stock | 13,665 | 8.40 | 114.8K | 0 | D | ↗ |
| 2024-11-21 | Autor Deborah M. | Director | S-Sale | D | Class A Common Stock | 6,771 | 8.41 | 56.9K | 86,631 | D | ↗ |
| 2024-11-15 | Daly Jason B. | Officer | S-Sale | D | Class A Common Stock | 43,657 | 8.61 | 375.9K | 13,665 | D | ↗ |
| 2024-08-15 | BOYER ANDREW S | Officer | S-Sale | D | Class A Common Stock | 40,225 | 7.85 | 315.8K | 256,670 | — | ↗ |
| 2024-08-14 | Shah Nikita | Officer | S-Sale | D | Class A Common Stock | 100,000 | 7.75 | 775.0K | 291,666 | — | ↗ |
| 2024-08-14 | BOYER ANDREW S | Officer | S-Sale | D | Class A Common Stock | 22,486 | 7.81 | 175.6K | 296,895 | — | ↗ |
| 2024-05-17 | Autor Deborah M. | Director | S-Sale | D | Class A Common Stock | 23,447 | 6.73 | 157.7K | 93,402 | — | ↗ |
| 2024-05-16 | Autor Deborah M. | Director | S-Sale | D | Class A Common Stock | 14,553 | 6.76 | 98.4K | 116,849 | — | ↗ |
| 2024-05-10 | Yanai Shlomo | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Patel Gautam | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Nark Ted C | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | MEISTER PAUL M | Director | M-Exempt | D | Restricted Stock Units | 107,034 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Kiely John | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | George Jeffrey P. | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | BUCHI J KEVIN | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Autor Deborah M. | Director | M-Exempt | D | Restricted Stock Units | 76,453 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Alva Emily Peterson | Director | M-Exempt | A | Class A Common Stock | 76,453 | 0.00 | — | 250,771 | — | ↗ |
| 2024-05-02 | Yanai Shlomo | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | Patel Gautam | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | Nark Ted C | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | MEISTER PAUL M | Director | A-Award | A | Restricted Stock Units | 56,361 | 0.00 | — | 56,361 | — | ↗ |
| 2024-05-02 | Kiely John | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | George Jeffrey P. | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | BUCHI J KEVIN | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | Autor Deborah M. | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-05-02 | Alva Emily Peterson | Director | A-Award | A | Restricted Stock Units | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2024-03-12 | Konidaris Tasos | Officer | M-Exempt | A | Class A Common Stock | 87,720 | 0.00 | — | 558,106 | — | ↗ |
| 2024-03-04 | Shah Nikita | Officer | A-Award | A | Restricted Stock Units | 143,519 | 0.00 | — | 143,519 | — | ↗ |
| 2024-03-04 | Patel Chirag K. | Director / Officer | A-Award | A | Restricted Stock Units | 370,370 | 0.00 | — | 370,370 | — | ↗ |
| 2024-03-04 | Patel Chintu | Director / Officer | A-Award | A | Restricted Stock Units | 370,370 | 0.00 | — | 370,370 | — | ↗ |
| 2024-03-04 | Konidaris Tasos | Officer | A-Award | A | Restricted Stock Units | 175,926 | 0.00 | — | 175,926 | — | ↗ |
| 2024-03-04 | Daly Jason B. | Officer | A-Award | A | Restricted Stock Units | 143,519 | 0.00 | — | 143,519 | — | ↗ |
| 2024-03-04 | BOYER ANDREW S | Officer | A-Award | A | Restricted Stock Units | 152,778 | 0.00 | — | 152,778 | — | ↗ |
| 2024-03-03 | Shah Nikita | Officer | F-InKind | D | Class A Common Stock | 18,153 | 5.47 | 99.3K | 368,777 | — | ↗ |
| 2024-03-03 | Konidaris Tasos | Officer | M-Exempt | A | Class A Common Stock | 57,339 | 0.00 | — | 490,512 | — | ↗ |
| 2024-03-03 | Daly Jason B. | Officer | F-InKind | D | Class A Common Stock | 7,166 | 5.47 | 39.2K | 29,960 | — | ↗ |
| 2024-03-03 | BOYER ANDREW S | Officer | F-InKind | D | Class A Common Stock | 19,665 | 5.47 | 107.6K | 294,584 | — | ↗ |
| 2024-03-01 | Shah Nikita | Officer | M-Exempt | A | Class A Common Stock | 28,957 | 0.00 | — | 365,879 | — | ↗ |
| 2024-03-01 | Konidaris Tasos | Officer | F-InKind | D | Class A Common Stock | 13,257 | 5.47 | 72.5K | 403,780 | — | ↗ |
| 2024-03-01 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 31,371 | 0.00 | — | 31,371 | — | ↗ |
| 2024-02-27 | Shah Nikita | Officer | M-Exempt | D | Restricted Stock Units | 35,620 | 0.00 | — | 0 | — | ↗ |
| 2024-02-27 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 31,663 | 0.00 | — | 0 | — | ↗ |
| 2024-01-01 | Patel Gautam | Director | G-Gift | A | Class A Common Stock | 1,598,115 | 0.00 | — | 1,972,433 | — | ↗ |
| 2023-11-07 | Patel Tushar Bhikhubhai | 10% Owner | J-Other | D | Class B Common Stock and Common Units | 53,578,209 | 0.00 | — | 0 | — | ↗ |
| 2023-11-07 | Patel Gautam | Director / 10% Owner | J-Other | D | Class B Common Stock and Common Units | 17,497,336 | 0.00 | — | 0 | — | ↗ |
| 2023-11-07 | Patel Dipan | — | J-Other | A | Class A Common Stock | 26,905,073 | 0.00 | — | 26,905,073 | — | ↗ |
| 2023-11-07 | Patel Chirag K. | Director / Officer | J-Other | D | Class B Common Stock and Common Units | 21,269,420 | 0.00 | — | 0 | — | ↗ |
| 2023-11-07 | Patel Chintu | Director / Officer | J-Other | A | Class A Common Stock | 24,753,252 | 0.00 | — | 24,753,252 | — | ↗ |
| 2023-08-11 | BOYER ANDREW S | Officer | S-Sale | D | Class A Common Stock | 29,302 | 4.13 | 120.9K | 244,739 | — | ↗ |
| 2023-07-30 | Autor Deborah M. | Director | M-Exempt | A | Class A Common Stock | 54,949 | 0.00 | — | 54,949 | — | ↗ |
| 2023-06-30 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 23,095 | 0.00 | — | 0 | — | ↗ |
| 2023-05-10 | Yanai Shlomo | Director | M-Exempt | D | Restricted Stock Units | 80,128 | 0.00 | — | 0 | — | ↗ |
| 2023-05-10 | Patel Gautam | Director | M-Exempt | A | Class A Common Stock | 80,128 | 0.00 | — | 374,318 | — | ↗ |
| 2023-05-10 | Nark Ted C | Director | M-Exempt | D | Restricted Stock Units | 80,128 | 0.00 | — | 0 | — | ↗ |
| 2023-05-10 | MEISTER PAUL M | Director | M-Exempt | A | Class A Common Stock | 112,179 | 0.00 | — | 620,658 | — | ↗ |
| 2023-05-10 | Kiely John | Director | M-Exempt | A | Class A Common Stock | 80,128 | 0.00 | — | 179,274 | — | ↗ |
| 2023-05-10 | George Jeffrey P. | Director | M-Exempt | D | Restricted Stock Units | 80,128 | 0.00 | — | 0 | — | ↗ |
| 2023-05-10 | BUCHI J KEVIN | Director | M-Exempt | A | Class A Common Stock | 80,128 | 0.00 | — | 185,619 | — | ↗ |
| 2023-05-10 | Alva Emily Peterson | Director | M-Exempt | A | Class A Common Stock | 80,128 | 0.00 | — | 174,318 | — | ↗ |
| 2023-05-09 | Yanai Shlomo | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | Patel Gautam | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | Nark Ted C | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | MEISTER PAUL M | Director | A-Award | A | Restricted Stock Units | 107,034 | 0.00 | — | 107,034 | — | ↗ |
| 2023-05-09 | Kiely John | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | George Jeffrey P. | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | BUCHI J KEVIN | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | Autor Deborah M. | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-05-09 | Alva Emily Peterson | Director | A-Award | A | Restricted Stock Units | 76,453 | 0.00 | — | 76,453 | — | ↗ |
| 2023-03-12 | Konidaris Tasos | Officer | M-Exempt | A | Class A Common Stock | 87,719 | 0.00 | — | 380,840 | — | ↗ |
| 2023-03-03 | Shah Nikita | Officer | A-Award | A | Restricted Stock Units | 183,486 | 0.00 | — | 183,486 | — | ↗ |
| 2023-03-03 | Patel Chirag K. | Director / Officer / 10% Owner | A-Award | A | Performance-Based Restricted Stock Units | 733,944 | 0.00 | — | 733,944 | — | ↗ |
| 2023-03-03 | Patel Chintu | Director / Officer | A-Award | A | Performance-Based Restricted Stock Units | 733,944 | 0.00 | — | 733,944 | — | ↗ |
| 2023-03-03 | Konidaris Tasos | Officer | M-Exempt | D | Restricted Stock Units | 45,289 | 0.00 | — | 135,870 | — | ↗ |
| 2023-03-03 | Daly Jason B. | Officer | F-InKind | D | Class A Common Stock | 8,164 | 1.92 | 15.7K | 14,481 | — | ↗ |
| 2023-03-03 | BOYER ANDREW S | Officer | A-Award | A | Performance-Based Restricted Stock Units | 397,554 | 0.00 | — | 397,554 | — | ↗ |
| 2023-03-01 | Shah Nikita | Officer | M-Exempt | D | Restricted Stock Units | 28,958 | 0.00 | — | 57,915 | — | ↗ |
| 2023-03-01 | Konidaris Tasos | Officer | M-Exempt | A | Class A Common Stock | 36,197 | 0.00 | — | 247,832 | — | ↗ |
| 2023-03-01 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 12,346 | 0.00 | — | 0 | — | ↗ |
| 2023-02-27 | Shah Nikita | Officer | M-Exempt | D | Restricted Stock Units | 35,620 | 0.00 | — | 35,620 | — | ↗ |
| 2023-02-27 | BOYER ANDREW S | Officer | M-Exempt | D | Restricted Stock Units | 31,662 | 0.00 | — | 31,663 | — | ↗ |
| 2022-12-12 | TPG GP A, LLC | Director | S-Sale | D | Class A Common Stock | 3,884,600 | 2.34 | 9.10M | 12,328,767 | — | ↗ |
| 2022-06-30 | BOYER ANDREW S | Officer | M-Exempt | A | Class A Common Stock | 23,094 | 0.00 | — | 219,678 | — | ↗ |
| 2022-05-09 | Yanai Shlomo | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | Patel Gautam | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | Nark Ted C | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | MEISTER PAUL M | Director | A-Award | A | Restricted Stock Units | 112,179 | 0.00 | — | 112,179 | — | ↗ |
| 2022-05-09 | Kiely John | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | George Jeffrey P. | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | BUCHI J KEVIN | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-09 | Alva Emily Peterson | Director | A-Award | A | Restricted Stock Units | 80,128 | 0.00 | — | 80,128 | — | ↗ |
| 2022-05-08 | Yanai Shlomo | Director | M-Exempt | D | Restricted Stock Units | 35,406 | 0.00 | — | 0 | — | ↗ |
| 2022-05-08 | Patel Gautam | Director | M-Exempt | D | Restricted Stock Units | 35,406 | 0.00 | — | 0 | — | ↗ |
| 2022-05-08 | Nark Ted C | Director | M-Exempt | A | Class A Common Stock | 35,406 | 0.00 | — | 144,190 | — | ↗ |
| 2022-05-08 | MEISTER PAUL M | Director | M-Exempt | A | Class A Common Stock | 52,677 | 0.00 | — | 508,479 | — | ↗ |
| 2022-05-08 | Kiely John | Director | M-Exempt | D | Restricted Stock Units | 35,406 | 0.00 | — | 0 | — | ↗ |
| 2022-05-08 | George Jeffrey P. | Director | M-Exempt | A | Class A Common Stock | 35,406 | 0.00 | — | 112,956 | — | ↗ |
| 2022-05-08 | BUCHI J KEVIN | Director | M-Exempt | A | Class A Common Stock | 35,406 | 0.00 | — | 105,491 | — | ↗ |
| 2022-05-08 | Alva Emily Peterson | Director | M-Exempt | D | Restricted Stock Units | 35,406 | 0.00 | — | 0 | — | ↗ |
| 2022-05-07 | Shah Nikita | Officer | M-Exempt | D | Restricted Stock Units | 4,442 | 0.00 | — | 0 | — | ↗ |
| 2022-05-07 | BOYER ANDREW S | Officer | M-Exempt | A | Class A Common Stock | 16,656 | 0.00 | — | 204,937 | — | ↗ |
| 2022-03-03 | Shah Nikita | Officer | A-Award | A | Restricted Stock Units | 144,928 | 0.00 | — | 144,928 | — | ↗ |
Executive team
Top executives
EBIT / Employee
45.8K
Shares Outstanding
319.02M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Chintu Patel Co-Chief Executive Officer | 800.0K | — | 6.97M | — | 848.0K | 107.6K | 8.73M | 79.89% | ↗ |
| 2 | 2025 | Chirag Patel Co-Chief Executive Officer and President | 800.0K | — | 6.97M | — | 848.0K | 68.8K | 8.69M | 80.25% | ↗ |
| 3 | 2025 | Anastasios Konidaris EVP & Chief Financial Officer | 600.8K | — | 2.25M | — | 423.6K | 19.2K | 3.29M | 68.32% | ↗ |
| 4 | 2025 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 613.8K | — | 1.91M | — | 471.7K | 19.2K | 3.02M | 63.39% | ↗ |
| 5 | 2025 | Jason Daly EVP, Chief Legal Officer & Secretary | 560.0K | — | 1.91M | — | 368.8K | 19.2K | 2.86M | 66.86% | ↗ |
| 6 | 2025 | Nikita Shah EVP, Chief Human Resources Officer | 518.8K | — | 1.86M | — | 336.4K | 19.2K | 2.73M | 67.98% | ↗ |
| 7 | 2024 | Chintu Patel Co-Chief Executive Officer | 788.5K | — | 5.47M | — | 880.0K | 49.3K | 7.19M | 76.11% | ↗ |
| 8 | 2024 | Chirag Patel Co-Chief Executive Officer and President | 788.5K | — | 5.47M | — | 880.0K | 46.2K | 7.19M | 76.15% | ↗ |
| 9 | 2024 | Anastasios Konidaris EVP & Chief Financial Officer | 580.7K | — | 1.87M | — | 386.1K | 18.9K | 2.85M | 65.44% | ↗ |
| 10 | 2024 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 600.0K | — | 1.62M | — | 554.4K | 18.9K | 2.79M | 58.01% | ↗ |
| 11 | 2024 | Nikita Shah EVP, Chief Human Resources Officer | 499.6K | — | 1.52M | — | 332.5K | 18.9K | 2.37M | 64.15% | ↗ |
| 12 | 2024 | Jason Daly EVP, Chief Legal Officer & Secretary | 502.7K | — | 1.52M | — | 308.6K | 18.9K | 2.35M | 64.72% | ↗ |
| 13 | 2023 | Chirag Patel Co-Chief Executive Officer and President | 750.0K | — | 664.2K | — | 910.5K | 45.7K | 2.37M | 28.02% | ↗ |
| 14 | 2023 | Chintu Patel Co-Chief Executive Officer | 750.0K | — | 664.2K | — | 910.5K | 42.8K | 2.37M | 28.06% | ↗ |
| 15 | 2023 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 600.0K | — | 741.4K | — | 582.7K | 18.5K | 1.94M | 38.17% | ↗ |
| 16 | 2023 | Anastasios Konidaris EVP & Chief Financial Officer | 563.3K | — | 855.5K | — | 453.9K | 18.5K | 1.89M | 45.23% | ↗ |
| 17 | 2023 | Nikita Shah EVP, Chief Human Resources Officer | 496.8K | — | 684.4K | — | 333.6K | 18.5K | 1.53M | 44.64% | ↗ |
| 18 | 2023 | Jason Daly EVP, Chief Legal Officer & Secretary | 470.1K | — | 570.3K | — | 290.5K | 18.5K | 1.35M | 42.27% | ↗ |
| 19 | 2023 | Jason Daly Senior Vice President, Chief Legal Officer & Secretary | 470.1K | — | 570.3K | — | 290.5K | 18.5K | 1.35M | 42.27% | ↗ |
| 20 | 2022 | Chintu Patel Co-Chief Executive Officer | 750.0K | — | 3.61M | — | 652.5K | 54.4K | 5.06M | 71.22% | ↗ |
| 21 | 2022 | Chirag Patel Co-Chief Executive Officer and President | 750.0K | — | 3.61M | — | 652.5K | 39.8K | 5.05M | 71.43% | ↗ |
| 22 | 2022 | Anastasios Konidaris EVP & Chief Financial Officer | 550.0K | — | 1.88M | — | 289.5K | 16.9K | 2.73M | 68.67% | ↗ |
| 23 | 2022 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 600.0K | — | 1.63M | — | 438.5K | 16.9K | 2.68M | 60.65% | ↗ |
| 24 | 2022 | Nikita Shah EVP, Chief Human Resources Officer | 485.0K | — | 1.50M | — | 255.5K | 16.9K | 2.26M | 66.47% | ↗ |
| 25 | 2022 | Jason Daly Senior Vice President, Chief Legal Officer & Secretary | 401.5K | 175.0K | 938.4K | — | 189.2K | 16.8K | 1.72M | 54.53% | ↗ |
| 26 | 2022 | Jason Daly EVP, Chief Legal Officer & Secretary | 401.5K | 175.0K | 938.4K | — | 189.2K | 16.8K | 1.72M | 54.53% | ↗ |
| 27 | 2021 | Chintu Patel Co-Chief Executive Officer | 724.0K | — | 3.27M | — | 757.5K | 50.9K | 4.80M | 68.07% | ↗ |
| 28 | 2021 | Chirag Patel Co-Chief Executive Officer and President | 724.0K | — | 3.27M | — | 757.5K | 37.2K | 4.79M | 68.26% | ↗ |
| 29 | 2021 | Anastasios Konidaris EVP & Chief Financial Officer | 550.0K | — | 1.77M | — | 326.9K | 16.3K | 2.66M | 66.47% | ↗ |
| 30 | 2021 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 600.0K | — | 1.53M | — | 484.8K | 16.4K | 2.64M | 58.22% | ↗ |
| 31 | 2021 | Nikita Shah EVP, CHRO & Strategic Planning Officer | 483.8K | — | 1.42M | — | 307.1K | 16.2K | 2.22M | 63.70% | ↗ |
| 32 | 2021 | Nikita Shah EVP, Chief Human Resources Officer | 483.8K | — | 1.42M | — | 307.1K | 16.2K | 2.22M | 63.70% | ↗ |
| 33 | 2021 | Joseph Todisco EVP, Chief Commercial Officer - Specialty | 523.6K | — | 1.30M | — | 318.2K | 16.3K | 2.16M | 60.21% | ↗ |
| 34 | 2020 | Anastasios Konidaris EVP & Chief Financial Officer | 427.3K | — | 1.75M | — | 327.6K | 6.2K | 2.51M | 69.66% | ↗ |
| 35 | 2020 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 660.1K | — | 1.24M | — | 492.5K | 16.2K | 2.39M | 51.95% | ↗ |
| 36 | 2020 | Chintu Patel Co-Chief Executive Officer | 1.00 | — | 2.30M | — | — | 29.8K | 2.33M | 98.72% | ↗ |
| 37 | 2020 | Chirag Patel Co-Chief Executive Officer and President | 1.00 | — | 2.30M | — | — | 22.0K | 2.32M | 99.05% | ↗ |
| 38 | 2020 | Chirag Patel President & Co-Chief Executive Officer | 1.00 | — | 2.30M | — | — | 22.0K | 2.32M | 99.05% | ↗ |
| 39 | 2020 | Nikita Shah EVP, CHRO & Strategic Planning Officer | 422.5K | — | 1.06M | — | 282.2K | 15.9K | 1.78M | 59.47% | ↗ |
| 40 | 2020 | Nikita Shah EVP, Chief Human Resources Officer | 422.5K | — | 1.06M | — | 282.2K | 15.9K | 1.78M | 59.47% | ↗ |
| 41 | 2020 | Joseph Todisco EVP, Chief Commercial Officer - Specialty | 458.5K | — | 881.0K | — | 315.2K | 16.4K | 1.67M | 52.72% | ↗ |
| 42 | 2020 | Todd P. Branning Former SVP & CFO | 179.9K | — | 616.7K | — | 75.1K | 398.7K | 1.27M | 48.54% | ↗ |
| 43 | 2019 | Robert A. Stewart Former President & CEO | 1.02M | — | 5.56M | 2.67M | — | 273.5K | 9.53M | 86.41% | ↗ |
| 44 | 2019 | Paul Bisaro Former Executive Chairman | 503.6K | — | 2.43M | 1.17M | — | 14.6K | 4.12M | 87.42% | ↗ |
| 45 | 2019 | David A. Buchen Former SVP, Chief Legal Officer | 561.7K | 75.0K | 1.50M | 1.50M | — | 15.0K | 3.65M | 82.15% | ↗ |
| 46 | 2019 | Pradeep Bhadauria Former Chief Scientific Officer | 399.8K | 750.0K | 1,000.0K | 1.15M | — | 56.3K | 3.36M | 64.07% | ↗ |
| 47 | 2019 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 660.1K | — | 1.39M | 1.05M | — | 15.0K | 3.11M | 78.31% | ↗ |
| 48 | 2019 | Andrew Boyer EVP, Commercial Operations | 660.1K | — | 1.39M | 1.05M | — | 15.0K | 3.11M | 78.31% | ↗ |
| 49 | 2019 | Todd P. Branning Former SVP & CFO | 487.2K | — | 1.00M | 1.15M | — | 14.9K | 2.66M | 81.09% | ↗ |
| 50 | 2019 | Nikita Shah EVP, CHRO & Strategic Planning Officer | 402.6K | — | 1.32M | 802.7K | — | 15.0K | 2.54M | 83.57% | ↗ |
| 51 | 2019 | Bryan Reasons Former SVP & CFO | 189.4K | — | — | — | — | 1.66M | 1.85M | 0.00% | ↗ |
| 52 | 2019 | Chintu Patel Co-Chief Executive Officer | 44.2K | — | 90.7K | 184.2K | — | 20.4K | 339.6K | 80.98% | ↗ |
| 53 | 2019 | Chintu Patel Co-CEO | 44.2K | — | 90.7K | 184.2K | — | 20.4K | 339.6K | 80.98% | ↗ |
| 54 | 2019 | Chirag Patel President & Co-CEO | 44.2K | — | 90.7K | 184.2K | — | 18.7K | 338.0K | 81.37% | ↗ |
| 55 | 2019 | Chirag Patel Co-Chief Executive Officer and President | 44.2K | — | 90.7K | 184.2K | — | 18.7K | 338.0K | 81.37% | ↗ |
| 56 | 2019 | Chirag Patel President & Co-Chief Executive Officer | 44.2K | — | 90.7K | 184.2K | — | 18.7K | 338.0K | 81.37% | ↗ |
| 57 | 2018 | Robert A. Stewart Former President & CEO | 634.6K | — | 5.00M | 5.00M | 1.00M | 49.2K | 11.68M | 85.59% | ↗ |
| 58 | 2018 | Robert A. Stewart President and Chief Executive Officer | 634.6K | — | 5.00M | 5.00M | 1.00M | 49.2K | 11.68M | 85.59% | ↗ |
| 59 | 2018 | Paul Bisaro Executive Chairman, Former President and Chief Executive Officer | 802.9K | — | 1.50M | 3.00M | 750.0K | 13.1K | 6.07M | 74.18% | ↗ |
| 60 | 2018 | Paul Bisaro Former Executive Chairman | 802.9K | — | 1.50M | 3.00M | 750.0K | 13.1K | 6.07M | 74.18% | ↗ |
| 61 | 2018 | Andrew Boyer EVP, Chief Commercial Officer - Generics | 412.5K | — | 1,000.0K | 2.00M | 448.1K | 924.00 | 3.86M | 77.69% | ↗ |
| 62 | 2018 | Andrew Boyer Executive Vice President, Commercial Operations | 412.5K | — | 1,000.0K | 2.00M | 448.1K | 924.00 | 3.86M | 77.69% | ↗ |
| 63 | 2018 | Andrew Boyer EVP, Commercial Operations | 412.5K | — | 1,000.0K | 2.00M | 448.1K | 924.00 | 3.86M | 77.69% | ↗ |
| 64 | 2018 | Bryan Reasons Former Senior Vice President and Chief Financial Officer | 528.3K | — | 500.0K | 1.00M | 298.6K | 37.4K | 2.36M | 63.44% | ↗ |
| 65 | 2018 | Bryan Reasons Former SVP & CFO | 528.3K | — | 500.0K | 1.00M | 298.6K | 37.4K | 2.36M | 63.44% | ↗ |
| 66 | 2018 | Sheldon Hirt Former Senior Vice President, General Counsel and Corporate Secretary | 268.0K | 211.2K | 266.7K | 533.3K | — | 13.3K | 1.29M | 61.90% | ↗ |
| 67 | 2018 | Nikita Shah EVP, CHRO & Strategic Planning Officer | 246.1K | — | 266.7K | 533.3K | 227.9K | 11.4K | 1.29M | 62.24% | ↗ |
| 68 | 2018 | Nikita Shah Senior Vice President, Chief Human Resources Officer | 246.1K | — | 266.7K | 533.3K | 227.9K | 11.4K | 1.29M | 62.24% | ↗ |
| 69 | 2017 | Paul Bisaro Executive Chairman, Former President and Chief Executive Officer | 621.2K | — | — | 5.29M | 624.4K | — | 6.53M | 80.93% | ↗ |
| 70 | 2017 | Paul Bisaro Former Executive Chairman | 621.2K | — | — | 5.29M | 624.4K | — | 6.53M | 80.93% | ↗ |
| 71 | 2017 | Bryan Reasons Former SVP & CFO | 512.7K | — | 217.6K | 251.2K | 283.1K | 49.5K | 1.31M | 35.67% | ↗ |
| 72 | 2017 | Bryan Reasons Former Senior Vice President and Chief Financial Officer | 512.7K | — | 217.6K | 251.2K | 283.1K | 49.5K | 1.31M | 35.67% | ↗ |
| 73 | 2016 | Bryan Reasons Former Senior Vice President and Chief Financial Officer | 496.6K | — | 868.8K | 826.5K | — | 56.6K | 2.25M | 75.40% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chintu Patel | Co-Founder, Co-CEO & Director | 2M | male |
| Chirag K. Patel | Co-Founder, Co-CEO, President & Director | 2M | male |
| Andrew S. Boyer | Executive Vice President and Chief Commercial Officer of Generics & Biosciences | 1M | male |
| Anastasios G. Konidaris | Executive Vice President & Chief Financial Officer | 1M | male |
| Jason Daly | Executive Vice President, Chief Legal Officer & Corporate Secretary | 947.9K | male |
| Nikita Shah | Executive Vice President & Chief Human Resources Officer | 874.3K | female |
| Anthony DiMeo | Head/VP of Investor Relations | — | male |
| Gregory Sgammato | Senior Vice President of Corporate Development | — | male |
| Sanjay Kumar Jain | Chief Quality Officer | — | male |
| Srinivas Kone | Senior Vice President & Chief Scientific Officer of Generics | — | — |
| Stanley Fisher | Vice President & Head of Medical Affairs | — | — |
| Pranav Mehta | Senior Vice President of Strategic Sourcing & Supply Management | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2019-05-24 | 2019-06-15 | Josh Gottheimer | NJ05 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AMRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
